Formoterol dry-powder inhalation - Novartis/SkyePharma
At a glance
- Drug Originator SkyePharma PLC
- Drug Licenced by Novartis; Schering-Plough
- Drug Class Antiasthmatics; Bronchodilators; Ethanolamines; Small molecules
- Mechanism of Action Beta 2 adrenergic receptor agonists
- USA Patent Applicants NOVARTIS
- USA Patents 2
- NDAs 1
- Patent Applications 1,107
Table of Contents
Disclaimer